|
US5795587A
(en)
|
1995-01-23 |
1998-08-18 |
University Of Pittsburgh |
Stable lipid-comprising drug delivery complexes and methods for their production
|
|
US6008202A
(en)
*
|
1995-01-23 |
1999-12-28 |
University Of Pittsburgh |
Stable lipid-comprising drug delivery complexes and methods for their production
|
|
ES2392246T3
(es)
*
|
1996-11-12 |
2012-12-07 |
The Regents Of The University Of California |
Preparación de formulaciones estables de complejos de lípido-ácido nucleico para el suministro eficaz in vivo
|
|
US6210707B1
(en)
*
|
1996-11-12 |
2001-04-03 |
The Regents Of The University Of California |
Methods of forming protein-linked lipidic microparticles, and compositions thereof
|
|
NZ333334A
(en)
*
|
1997-04-17 |
2001-06-29 |
Frank L Sorgi |
Delivery system for gene therapy to the brain
|
|
US6749863B1
(en)
|
1997-11-19 |
2004-06-15 |
Georgetown University |
Targeted liposome gene delivery
|
|
AU747597B2
(en)
*
|
1998-07-20 |
2002-05-16 |
Inex Pharmaceuticals Corporation |
Liposomal encapsulated nucleic acid-complexes
|
|
JP4799736B2
(ja)
*
|
1999-02-22 |
2011-10-26 |
ジョージタウン・ユニバーシティ |
全身性遺伝子送達のための抗体フラグメント標的化イムノリポソーム
|
|
US9034329B2
(en)
|
1999-02-22 |
2015-05-19 |
Georgetown University |
Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof
|
|
US7780882B2
(en)
|
1999-02-22 |
2010-08-24 |
Georgetown University |
Simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome for systemic administration of a therapeutic or diagnostic agent
|
|
US9034330B2
(en)
|
1999-02-22 |
2015-05-19 |
Georgetown University |
Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof
|
|
EP1156783B1
(en)
*
|
1999-03-02 |
2007-10-24 |
Transave, Inc. |
Encapsulation of bioactive complexes in liposomes
|
|
AU5161800A
(en)
*
|
1999-05-24 |
2000-12-12 |
Board Of Regents, The University Of Texas System |
Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases
|
|
EP1754488A1
(en)
*
|
1999-05-24 |
2007-02-21 |
Introgen Therapeutics, Inc. |
Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases
|
|
US7067111B1
(en)
*
|
1999-10-25 |
2006-06-27 |
Board Of Regents, University Of Texas System |
Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
|
|
US7189705B2
(en)
*
|
2000-04-20 |
2007-03-13 |
The University Of British Columbia |
Methods of enhancing SPLP-mediated transfection using endosomal membrane destabilizers
|
|
US10293056B1
(en)
|
2000-05-24 |
2019-05-21 |
Board Of Regents, The University Of Texas System |
Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases
|
|
IL153218A0
(en)
|
2000-06-02 |
2003-07-06 |
Univ Texas |
Ethylenedicysteine (ec) -drug conjugates
|
|
CA2422524A1
(en)
*
|
2000-09-25 |
2002-03-28 |
Motoyuki Yamashita |
Pei: dna vector formulations for in vitro and in vivo gene delivery
|
|
US20020146829A1
(en)
*
|
2000-11-29 |
2002-10-10 |
Aventis Pharmaceuticals Products Inc. |
Neutral and anionic colloidal particles for gene delivery
|
|
AU2002307035A1
(en)
*
|
2001-04-02 |
2002-10-15 |
Georgetown University |
A simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome or polyplex for systemic administration of a therapeutic or diagnostic agent
|
|
EP1610751A4
(en)
*
|
2001-04-26 |
2006-05-24 |
Univ Texas |
THERAPEUTIC AGENT / LIGAND CONJUGATE COMPOSITIONS, ITS SYNTHESIS PROCESSES AND ITS APPLICATION
|
|
JP2004535388A
(ja)
*
|
2001-04-30 |
2004-11-25 |
ターゲティッド ジェネティクス コーポレイション |
脂質含有薬物送達複合体およびそれらの生成方法
|
|
US20050261214A1
(en)
*
|
2001-05-15 |
2005-11-24 |
Serge Braun |
Complexes for transferring substances of interest into a cell
|
|
FR2829136B1
(fr)
*
|
2001-08-29 |
2006-11-17 |
Aventis Pharma Sa |
Derives lipidiques d'aminoglycosides
|
|
US20030049203A1
(en)
*
|
2001-08-31 |
2003-03-13 |
Elmaleh David R. |
Targeted nucleic acid constructs and uses related thereto
|
|
US7261875B2
(en)
*
|
2001-12-21 |
2007-08-28 |
Board Of Regents, The University Of Texas System |
Dendritic poly (amino acid) carriers and methods of use
|
|
KR100466254B1
(ko)
*
|
2002-02-25 |
2005-01-14 |
한국과학기술원 |
세포내 전달을 위한 올리고뉴클레오티드와 친수성 고분자로 구성되는 유전자 전달용 접합체, 고분자 전해질 복합 미셀 및 그의 제조방법
|
|
WO2003097805A2
(en)
|
2002-05-15 |
2003-11-27 |
California Pacific Medical Center |
Delivery of nucleic acid-like compounds
|
|
US20040137064A1
(en)
*
|
2003-01-15 |
2004-07-15 |
Lewis David L. |
Compositions and processes using siRNA, amphipathic compounds and polycations
|
|
WO2003106636A2
(en)
*
|
2002-06-14 |
2003-12-24 |
Mirus Corporation |
Novel methods for the delivery of polynucleotides to cells
|
|
KR101086690B1
(ko)
*
|
2002-11-07 |
2011-11-25 |
셀>포인트, 엘엘씨 |
에틸렌디시스테인（ｅｃ）－약물 콘쥬게이트, 조성물 및조직 특이적 질환 영상 방법
|
|
ES2371913T3
(es)
|
2003-01-22 |
2012-01-11 |
Duke University |
Constructos mejorados para expresar polipéptidos lisosomales.
|
|
US7678540B2
(en)
*
|
2003-10-16 |
2010-03-16 |
University Of Massachusetts |
Template-directed assembly of receptor signaling complexes
|
|
US9050378B2
(en)
*
|
2003-12-10 |
2015-06-09 |
Board Of Regents, The University Of Texas System |
N2S2 chelate-targeting ligand conjugates
|
|
US20050261221A1
(en)
*
|
2004-03-01 |
2005-11-24 |
Li Wang |
Compositions and methods for enhanced delivery of compounds via transfection complexes
|
|
CA2562499A1
(en)
*
|
2004-04-09 |
2005-11-24 |
Biodelivery Sciences International, Inc. |
Nucleotide-cochleate compositions and methods of use
|
|
US20090005332A1
(en)
*
|
2004-12-30 |
2009-01-01 |
Hauser Todd M |
Compositions and Methods for Modulating Gene Expression Using Self-Protected Oligonucleotides
|
|
US20090011003A1
(en)
*
|
2005-01-28 |
2009-01-08 |
Kyowa Hakko Kogyo Co., Ltd. |
Composition for Suppressing Expression of Target Gene
|
|
EP1970078A4
(en)
*
|
2006-01-11 |
2010-11-17 |
Kyowa Hakko Kirin Co Ltd |
COMPOSITION FOR INHIBITING A TARGET GENE IN AN EYEBORN AND REMEDY FOR ACAPIC DISEASE
|
|
JP2009531438A
(ja)
*
|
2006-03-24 |
2009-09-03 |
ジェンシア コーポレイション |
合成脂質ラフトおよび使用方法
|
|
US8758723B2
(en)
|
2006-04-19 |
2014-06-24 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods for cellular imaging and therapy
|
|
DK2019683T4
(da)
|
2006-04-25 |
2022-08-29 |
Univ California |
Indgivelse af vækstfaktorer til behandling af CNS-lidelser
|
|
US20070259031A1
(en)
*
|
2006-04-26 |
2007-11-08 |
The Regents Of The University Of California |
Compositions and methods for convection enhanced delivery of high molecular weight neurotherapeutics
|
|
WO2008002656A2
(en)
*
|
2006-06-28 |
2008-01-03 |
P.A. Technologies Llc |
Methods and materials for in vitro analysis and/or use of membrane-associated proteins, portions thereof or variants thereof
|
|
US20080213349A1
(en)
*
|
2006-09-11 |
2008-09-04 |
Deepak Ramesh Thakker |
Liposome Complexes Containing Pharmaceutical Agents and Methods
|
|
EP2069500B1
(en)
*
|
2006-10-04 |
2014-09-24 |
Centre National De La Recherche Scientifique (Cnrs) |
Compositions comprising a sirna and lipidic 4,5-disubstituted 2-deoxystreptamine ring aminoglycoside derivatives and uses thereof
|
|
US10925977B2
(en)
|
2006-10-05 |
2021-02-23 |
Ceil>Point, LLC |
Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
|
|
CN101678082B
(zh)
|
2007-03-26 |
2013-06-19 |
再生医药有限公司 |
使用cxcl9和抗cxcl9抗体促进骨髓保护和再生的方法
|
|
CA2692546C
(en)
*
|
2007-07-09 |
2018-03-13 |
Esther H. Chang |
Methods for generating immune response using cationic-liposome-mediated nucleic acid delivery
|
|
CA2727428A1
(en)
*
|
2008-06-19 |
2009-12-23 |
Nippon Shinyaku Co., Ltd. |
Drug carrier
|
|
WO2010074540A2
(ko)
*
|
2008-12-26 |
2010-07-01 |
주식회사 삼양사 |
음이온성 약물 함유 약제학적 조성물 및 그 제조방법
|
|
US9459247B2
(en)
|
2010-03-29 |
2016-10-04 |
Academia Sinica |
Quantitative measurement of nano/micro particle endocytosis with cell mass spectrometry
|
|
RU2436583C1
(ru)
*
|
2010-07-06 |
2011-12-20 |
Общество с ограниченной ответственностью "ВИТАЛАНГ" |
Противовирусное средство
|
|
JP5760562B2
(ja)
*
|
2011-03-22 |
2015-08-12 |
セイコーエプソン株式会社 |
読取装置および読取方法
|
|
EP2760463B1
(en)
|
2011-09-20 |
2018-11-21 |
The University of North Carolina At Chapel Hill |
Regulation of sodium channels by plunc proteins
|
|
US9238865B2
(en)
|
2012-02-06 |
2016-01-19 |
Asm Ip Holding B.V. |
Multiple vapor sources for vapor deposition
|
|
WO2016045732A1
(en)
|
2014-09-25 |
2016-03-31 |
Biontech Rna Pharmaceuticals Gmbh |
Stable formulations of lipids and liposomes
|
|
WO2017127473A1
(en)
|
2016-01-19 |
2017-07-27 |
The University Of North Carolina At Chapel Hill |
Methods and compositions using rna interference for inhibition of kras
|
|
US10894811B2
(en)
|
2016-02-22 |
2021-01-19 |
The University Of North Carolina At Chapel Hill |
Peptide inhibitors of calcium channels
|
|
US11788190B2
(en)
|
2019-07-05 |
2023-10-17 |
Asm Ip Holding B.V. |
Liquid vaporizer
|
|
JP2022540819A
(ja)
*
|
2019-07-10 |
2022-09-20 |
ユニバーシティ オブ ワシントン |
非ウイルス性免疫標的化
|
|
US11946136B2
(en)
|
2019-09-20 |
2024-04-02 |
Asm Ip Holding B.V. |
Semiconductor processing device
|
|
GB202004254D0
(en)
|
2020-03-24 |
2020-05-06 |
Puridify Ltd |
Characterization of gene therapy vectors
|
|
WO2023054243A1
(ja)
*
|
2021-09-30 |
2023-04-06 |
日油株式会社 |
細胞指向性を有する脂質ナノ粒子
|
|
DE102023001946A1
(de)
*
|
2023-05-12 |
2024-11-14 |
Friedrich-Schiller-Universität Jena, Körperschaft des öffentlichen Rechts |
Nanopartikel für den Transport von Wirkstoffen mit anionischen Gruppen, Verfahren zu deren Herstellung und deren Verwendung
|
|
CN119490670A
(zh)
*
|
2024-11-26 |
2025-02-21 |
山东大学 |
一种慢病毒转染增强纳米颗粒及其制备方法与应用
|